TXG (STOCKS)
10x Genomics, Inc. Class A Common Stock
$23.159200
-0.110800 (-0.48%)
Prev close: $23.270000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Serge Saxonov
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,013.04M
- Employees
- 1,306
- P/E (TTM)
- -66.56
- P/B (TTM)
- 3.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
4
Buy
13
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.13 | $-0.21 | +0.0846 | +39.42% |
|
Sep 2025 (Q3)
|
$-0.22 | $-0.29 | +0.0710 | +24.40% |
|
Jun 2025 (Q2)
|
$0.28 | $-0.38 | +0.6553 | +174.61% |
|
Mar 2025 (Q1)
|
$-0.36 | $-0.48 | +0.1159 | +24.35% |
Financial Statements
| Revenues | $642.82M |
| Benefits Costs and Expenses | $682.73M |
| Cost Of Revenue | $198.94M |
| Costs And Expenses | $682.73M |
| Gross Profit | $443.88M |
| Nonoperating Income/Loss | $21.08M |
| Operating Expenses | $504.87M |
| Selling, General, and Administrative Expenses | $316.13M |
| Other Operating Expenses | $188.73M |
| Operating Income/Loss | -$60.99M |
| Income/Loss From Continuing Operations After Tax | -$43.54M |
| Income/Loss From Continuing Operations Before Tax | -$39.91M |
| Income Tax Expense/Benefit | $3.64M |
| Income Tax Expense/Benefit, Current | $3.95M |
| Income Tax Expense/Benefit, Deferred | -$310.00K |
| Net Income/Loss | -$43.54M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$43.54M |
| Net Income/Loss Available To Common Stockholders, Basic | -$43.54M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.35 |
| Diluted Earnings Per Share | -$0.35 |
| Basic Average Shares | 124,749,885 |
| Diluted Average Shares | 124,749,885 |
| Assets | $1.04B |
| Current Assets | $684.45M |
| Inventory | $56.34M |
| Other Current Assets | $628.11M |
| Noncurrent Assets | $356.91M |
| Fixed Assets | $226.71M |
| Intangible Assets | $62.33M |
| Other Non-current Assets | $67.87M |
| Liabilities | $245.04M |
| Current Liabilities | $153.45M |
| Accounts Payable | $12.73M |
| Wages | $42.50M |
| Other Current Liabilities | $98.22M |
| Noncurrent Liabilities | $91.59M |
| Equity | $796.33M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $796.33M |
| Liabilities And Equity | $1.04B |
| Net Cash Flow From Operating Activities | $136.05M |
| Net Cash Flow From Operating Activities, Continuing | $136.05M |
| Net Cash Flow From Investing Activities | -$13.44M |
| Net Cash Flow From Investing Activities, Continuing | -$13.44M |
| Net Cash Flow From Financing Activities | $6.80M |
| Net Cash Flow From Financing Activities, Continuing | $6.80M |
| Exchange Gains/Losses | $484.00K |
| Net Cash Flow | $129.90M |
| Net Cash Flow, Continuing | $129.42M |
| Comprehensive Income/Loss | -$42.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$42.83M |
| Other Comprehensive Income/Loss | -$42.83M |
| Other Comprehensive Income/Loss Attributable To Parent | $718.00K |